ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $4.02 billion. The enterprise value is $5.01 billion.
| Market Cap | 4.02B |
| Enterprise Value | 5.01B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 25.01 million shares outstanding. The number of shares has increased by 2.28% in one year.
| Current Share Class | 25.01M |
| Shares Outstanding | 25.01M |
| Shares Change (YoY) | +2.28% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | 1.77% |
| Owned by Institutions (%) | 105.57% |
| Float | 24.56M |
Valuation Ratios
The trailing PE ratio is 133.66 and the forward PE ratio is 52.24. ICU Medical's PEG ratio is 4.75.
| PE Ratio | 133.66 |
| Forward PE | 52.24 |
| PS Ratio | 1.86 |
| Forward PS | 1.80 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 40.31 |
| P/FCF Ratio | 26.33 |
| P/OCF Ratio | 17.02 |
| PEG Ratio | 4.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.36, with an EV/FCF ratio of 32.77.
| EV / Earnings | 166.44 |
| EV / Sales | 2.32 |
| EV / EBITDA | 15.36 |
| EV / EBIT | 40.11 |
| EV / FCF | 32.77 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.43 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 3.76 |
| Debt / FCF | 8.42 |
| Interest Coverage | 1.52 |
Financial Efficiency
Return on equity (ROE) is 1.41% and return on invested capital (ROIC) is 3.96%.
| Return on Equity (ROE) | 1.41% |
| Return on Assets (ROA) | 1.93% |
| Return on Invested Capital (ROIC) | 3.96% |
| Return on Capital Employed (ROCE) | 3.60% |
| Weighted Average Cost of Capital (WACC) | 7.59% |
| Revenue Per Employee | $166,123 |
| Profits Per Employee | $2,315 |
| Employee Count | 13,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.18 |
Taxes
| Income Tax | -30.96M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.59% in the last 52 weeks. The beta is 0.76, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +22.59% |
| 50-Day Moving Average | 167.47 |
| 200-Day Moving Average | 145.73 |
| Relative Strength Index (RSI) | 33.78 |
| Average Volume (20 Days) | 235,744 |
Short Selling Information
The latest short interest is 1.38 million, so 5.54% of the outstanding shares have been sold short.
| Short Interest | 1.38M |
| Short Previous Month | 1.39M |
| Short % of Shares Out | 5.54% |
| Short % of Float | 5.64% |
| Short Ratio (days to cover) | 4.11 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.16 billion and earned $30.09 million in profits. Earnings per share was $1.20.
| Revenue | 2.16B |
| Gross Profit | 826.25M |
| Operating Income | 124.85M |
| Pretax Income | -866,000 |
| Net Income | 30.09M |
| EBITDA | 326.12M |
| EBIT | 124.85M |
| Earnings Per Share (EPS) | $1.20 |
Balance Sheet
The company has $302.64 million in cash and $1.29 billion in debt, with a net cash position of -$984.52 million or -$39.37 per share.
| Cash & Cash Equivalents | 302.64M |
| Total Debt | 1.29B |
| Net Cash | -984.52M |
| Net Cash Per Share | -$39.37 |
| Equity (Book Value) | 2.15B |
| Book Value Per Share | 86.05 |
| Working Capital | 712.54M |
Cash Flow
In the last 12 months, operating cash flow was $236.37 million and capital expenditures -$83.54 million, giving a free cash flow of $152.83 million.
| Operating Cash Flow | 236.37M |
| Capital Expenditures | -83.54M |
| Depreciation & Amortization | 201.27M |
| Net Borrowing | -111.84M |
| Free Cash Flow | 152.83M |
| FCF Per Share | $6.11 |
Margins
Gross margin is 38.26%, with operating and profit margins of 5.78% and 1.39%.
| Gross Margin | 38.26% |
| Operating Margin | 5.78% |
| Pretax Margin | -0.04% |
| Profit Margin | 1.39% |
| EBITDA Margin | 15.10% |
| EBIT Margin | 5.78% |
| FCF Margin | 7.08% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.28% |
| Shareholder Yield | -2.28% |
| Earnings Yield | 0.75% |
| FCF Yield | 3.80% |
Analyst Forecast
The average price target for ICU Medical is $193.38, which is 20.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $193.38 |
| Price Target Difference | 20.19% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 2.41% |
| EPS Growth Forecast (3Y) | 10.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 2.21 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.21 |
| Piotroski F-Score | 6 |